HOME >> BIOLOGY >> NEWS
Inflammation markers identify fatigue in breast cancer survivors

PHILADELHPIA -- Researchers at the University of California, Los Angeles have defined conditions associated with disabling fatigue that persists for years in almost a third of breast cancer survivors, according to a study in the May 1 issue of Clinical Cancer Research.

The key to their fatigue stems from responses within their immune systems.

"These studies identify a biological basis for persistent fatigue in cancer survivors that is implemented by inflammation," said Michael Irwin, M.D., director and senior research scientist, Cousins Center for Psychoneuroimmunology, UCLA Semel Institute for Neuroscience, and the UCLA Jonsson Cancer Center.

"We have detected a biological marker that is a composite of two immune response elements," he added. "This biomarker identifies and can predict which women have long term persistent fatigue.

"These findings point the way for development of novel treatment strategies that decrease this inflammatory response and thwart the fatigue that these patients endure."

One component of the marker, Dr. Irwin explained, is a measure of the amount of interleukin-6 receptor (IL-6R) free-floating in the blood of breast cancer survivors compared to the amount of that receptor remaining on the membranes of specific blood cells where the receptor normally is found and functions within the immune response.

The IL-6R is usually embedded on the surface membrane of white blood cells, or monocytes. In some survivors, however, many of the IL-6R are shed from the monocytes and are soluble within the blood plasma. Those free-floating receptors can still bind to circulating cytokine IL-6, Dr. Irwin noted, and in that form have the potential to interact with cells that normally don't respond to cytokine/receptor activation such as brain cells that may regulate fatigue sensation.

IL6 is a biological chemical that helps drive initial immune responses within people. "IL-6 contribut
'"/>

Contact: Russell Vanderboom, Ph.D.
vanderboom@aacr.org
215-440-9300
American Association for Cancer Research
1-May-2006


Page: 1 2

Related biology news :

1. Inflammation may cause preterm labor and fetal deaths
2. Inflammation is at the origin and progression of diseases such as diabetes or cancer
3. Targeting tau: Inflammation study suggests new approach for fighting Alzheimers
4. Inflammation and drugs to control this activity studied in a variety of tumors sites
5. Research aims to identify markers for menopausal women at risk for deadly blood clot
6. Contributing membership in the biomarkers consortium surges to 30 companies and nonprofits
7. New tumor markers -- Spot the differences
8. Tumor vessels identified by unique molecular markers
9. Jaap Sinninghe Damst awarded the Vernadsky Medal for innovative use of biomarkers
10. Pancreatic cancer markers identified, may predict survival
11. Genes and biomarkers that allow doctors to choose the right therapy for the right patient

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/30/2020)... (PRWEB) , ... April 28, 2020 , ... Pebble ... world’s biggest challenges in agriculture and aquaculture with the mission of improving global food ... the 2020 F&A Next ' Next Heroes in Food- and Ag-Tech ' virtual event, ...
(Date:4/30/2020)... , ... April 29, 2020 , ... ... positioned for continued growth – delivering innovative solutions for a wide range of ... aerospace and government agencies. A month into the new decade, it was clear ...
(Date:4/26/2020)... , ... April 23, 2020 , ... ... in computer miniaturization, backed by FII Tech Growth managed by Fondo Italiano d’Investimento ... the biomedical market, for the development of Respira, a new non-invasive pulmonary ventilator ...
Breaking Biology News(10 mins):
(Date:5/21/2020)... ... 2020 , ... Threats to intellectual property, political pressure to ... conventional wisdom that says the coronavirus pandemic will generally benefit biopharmaceutical companies, a ... pandemic commercially weaker, dealing with delays in new product launches and with fewer ...
(Date:5/21/2020)... ... May 20, 2020 , ... ... Prakash, who will serve as the company’s executive vice president of product engineering ... Exo is disrupting the medical imaging space, bringing more than 24 years of ...
(Date:5/15/2020)... ... 2020 , ... This new service offers clients a way to speak with ... as the need arises. Lachman’s OnCall SMEs have extensive knowledge of a wide range ... Lachman OnCall™ SMEs are available normal business hours Monday through Friday from 9:00 am ...
(Date:5/14/2020)... ... May 12, 2020 , ... NanoString ... bringing together thousands of industry leaders, clinicians, research scientists, medical professionals and academics ... Carl June, MD, Director of the Center for Cellular Immunotherapies at the Perelman ...
Breaking Biology Technology:
Cached News: